Cargando…
MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors
BACKGROUND: Non-coding RNAs and especially microRNAs have been discovered to act as master regulators of cancer initiation and progression. The aim of our study was to discover and characterize the function of yet functionally uncharacterized microRNAs in human breast carcinogenesis. METHODS: In an...
Autores principales: | Schwarzenbacher, Daniela, Klec, Christiane, Pasculli, Barbara, Cerk, Stefanie, Rinner, Beate, Karbiener, Michael, Ivan, Cristina, Barbano, Raffaela, Ling, Hui, Wulf-Goldenberg, Annika, Stanzer, Stefanie, Rinnerthaler, Gabriel, Stoeger, Herbert, Bauernhofer, Thomas, Haybaeck, Johannes, Hoefler, Gerald, Jahn, Stephan Wenzel, Parrella, Paola, Calin, George Adrian, Pichler, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359814/ https://www.ncbi.nlm.nih.gov/pubmed/30709367 http://dx.doi.org/10.1186/s13058-019-1104-5 |
Ejemplares similares
-
ALYREF, a novel factor involved in breast carcinogenesis, acts through transcriptional and post-transcriptional mechanisms selectively regulating the short NEAT1 isoform
por: Klec, Christiane, et al.
Publicado: (2022) -
MiR-4649-5p acts as a tumor-suppressive microRNA in triple negative breast cancer by direct interaction with PIP5K1C, thereby potentiating growth-inhibitory effects of the AKT inhibitor capivasertib
por: Jonas, Katharina, et al.
Publicado: (2023) -
Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023) -
Can Epigenetics of Endothelial Dysfunction Represent the Key to Precision Medicine in Type 2 Diabetes Mellitus?
por: Coco, Celeste, et al.
Publicado: (2019) -
Phosphoinositide 3-Kinase Inhibitor-Induced Hyperglycemia
por: Shey, Susan, et al.
Publicado: (2021)